Flagship Wealth Advisors’s Organon & Co OGN Stock Holding History

Flagship Wealth Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40	Closed	-$596	–	383
2025 Q1	$596	Hold	40	–	–	﹤0.01%	369
2024 Q4	$597	Buy	+40	New	+$652	﹤0.01%	363

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Flagship Wealth Advisors's OGN Position: Q2 2025 in Review

Flagship Wealth Advisors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 40 shares — an estimated $596 sold.

Flagship Wealth Advisors first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $597 in Q4 2024. 696 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Flagship Wealth Advisors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Flagship Wealth Advisors sold 40 Organon & Co shares in Q2 2025, an estimated $596.
Flagship Wealth Advisors first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
Flagship Wealth Advisors's Organon & Co position peaked at $597 in Q4 2024.
696 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Flagship Wealth Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.